News

Comphya Clinical Advisory Board in a Meeting

Comphya is delighted to announce the formation of the Clinical Advisory Board

10 February 2020

PRESS RELEASE Lausanne, Switzerland, February 07th, 2020 - Comphya SA, the developer of CaverSTIM™, the first implantable neurostimulator to restore erectile function in non-responders to...

Read more
Comphya SA and Cirtec Medical Corp. announce the partnership on the development of CaverSTIM

Comphya SA and Cirtec Medical Corp. announce the partnership on the development of CaverSTIM

25 October 2019

PRESS RELEASE Comphya SA announces partnership with Cirtec Medical Corp. on the development of the first implantable neurostimulator to treat Erectile Dysfunction. Lausanne, Switzerland, October...

Read more
Comphya raises USD 3.0 million in the first financing round and appoints Dr Steve Swinson as Chairman of the Board

Comphya raises USD 3.0 million in the first financing round and appoints Dr Steve Swinson as Chairman of the Board

25 July 2019

Comphya SA, a developer of a novel implantable neurostimulator to treat erectile dysfunction in non-responders to oral drugs, today announced the fundraising of USD 3.0...

Read more
First publication – Proof of concept

First publication – Proof of concept

15 November 2018

  Journal of Sexual Medicine published our results on the acute clinical trial (20 patients) which demonstrated the proof of the principle and technology feasibility....

Read more